These results are similar to a study of four EGFR-positive ovarian cancer cell lines (Sewell et al, 2002) where growth stimulation with TGFα, another ligand for EGFR, was completely inhibited by gefitinib concentrations of 0.3 μM and above. Here, EGFR is linked to ovarian cancer.